Skip to main content

Year: 2025

Landsbankinn hf.: Domestic Issue Calendar for 2026

Attached is a schedule of Landsbankinn‘s covered bond auctions in the domestic market in 2026. Landsbankinn will explore other funding opportunities, including issuance of subordinated securities, in the domestic market with the aim of diversifying the funding base. The timing and amount of such issuance will depend on market conditions and general investor interest.  Landsbankinn reserves the right to make changes to the schedule for 2026 at its own discretion without prior notice.AttachmentIssue calendar 2026

Continue reading

Mondelēz Global LLC Expands Voluntary Recall of 2 SKUs of CHIPS AHOY! Baked Bites Brookie in the US

EAST HANOVER, N.J., Dec. 30, 2025 (GLOBE NEWSWIRE) — Mondelēz Global LLC announced today an expansion of its December 24, 2025 voluntary recall in the United States of CHIPS AHOY! Baked Bites Brookie. This expansion includes one additional code date (10MAY2026) and two additional UPCs of product pouches inside the recalled carton units of CHIPS AHOY! Baked Bites Brookie. This voluntary recall is being conducted because of an incorrect mixing process that resulted in the formation of small corn starch clumps in the product. Due to the characteristics and size of the small starch clumps, the clump could constitute a choking hazard, particularly in special risk groups, such as young children and the elderly. This recall is limited exclusively to the CHIPS AHOY! Baked Bites Brookie products with Best When Used By Dates listed in the...

Continue reading

Resolutions of the Annual General Shareholders Meeting of VILNIAUS BALDAI AB on 30/12/2025

On the 30 of December 2025 the Annual General Shareholders Meeting of VILNIAUS BALDAI AB adopted the following resolutions:   Agenda item #1: Consolidated Management Report. The Company‘s consolidated management report for the FY 2025 ended 31 August 2025 was presented. Agenda item #2: Company‘s Auditor’s Report. The report of the audit company Grant Thornton Baltic UAB on the consolidated and the Company’s financial statements for the FY 2025, ended on 31 August 2025, was presented.   Agenda item #3: Approval of the Consolidated and Company’s financial statements for the year 2025 ended 31 August 2025. Resolution: to approve Consolidated and Company’s financial statements for the year 2025 ended 31 August, 2025.   Agenda item #4: Approval of the Company‘s profit distribution for the year 2025 ended 31 August 2025. Resolution:...

Continue reading

U.S. Global Investors Advances Smart Beta 2.0 Strategy as GOAU ETF Transitions to Active Management and WAR ETF Marks One-Year Milestone

GOAU Climbed Higher in 2025Market Price Per Share, Year-to-Date Through December 18, 2025The WAR ETF Has Outperformed the Market Since InceptionNAV Percent Change | Dec. 20, 2024 – Nov. 28., 2025San Antonio, TX, Dec. 30, 2025 (GLOBE NEWSWIRE) — U.S. Global Investors, Inc. (NASDAQ: GROW) (the “Company”), a registered investment advisory firm with longstanding experience in global markets and specialized sectors, is proud to celebrate two significant milestones on December 30, 2025. In a year marked by historic moves in gold, the U.S. Global GO GOLD and Precious Metals Miner ETF (GOAU) will transition from passive indexing to active management, enabling greater agility while remaining grounded in the Company’s proprietary Smart Beta 2.0 investment discipline. At the same time, the U.S. Global Technology...

Continue reading

Advanced Biomed Inc. Announces Disposal of its Hong Kong Subsidiary 

Tainan City, Taiwan, Dec. 30, 2025 (GLOBE NEWSWIRE) — Advanced Biomed Inc. (Nasdaq: ADVB) (the “Company”, “Advanced Biomed”), a biotechnology company focused on developing and commercializing innovative biomedical products for precision medicine and advanced diagnostics, today announced that on December 23, 2025, it entered into an agreement (the “Agreement”) with an unrelated third party, Wei Ha Hui (the “Buyer”), pursuant to which the Company agreed to sell 100% of the issued and outstanding shares of Advanced Biomed (HK) Limited, a Hong Kong company and a wholly owned subsidiary of the Company (the “Hong Kong Subsidiary”), for an aggregate purchase price of US$23,000 based on a valuation report commissioned by the Company, subject to the terms and conditions set forth in the Agreement. All intellectual property owned by the...

Continue reading

ILLR Remains Confident in Nasdaq Appeal and Imminent Filing Compliance

Los Angeles , Dec. 30, 2025 (GLOBE NEWSWIRE) — Triller Group Inc. (“Triller Group” or “the Company”) today announced that it received a determination letter from a Nasdaq Hearings Panel on December 26, 2025, confirming the suspension of trading on the Nasdaq Stock Market effective at the open of the market on December 30, 2025 and delisting of the Company’s securities. This decision stems from the Company not having been able to file two periodic reports by a deadline of December 24, 2025 set by the Hearings Panel. The Company’s operations have been progressing in a normal manner, and no deficiencies or irregularities have been identified that materially affect the Company’s financial position or operational integrity. The filing delay is attributable primarily to one remaining technical matter involving the consolidation of accounts...

Continue reading

Totaligent Evaluates Relaunch of Previously Operated Crypto Mining Activities as Part of 2026 Strategy

BOCA RATON, Fla., Dec. 30, 2025 (GLOBE NEWSWIRE) — Totaligent, Inc. (OTCID: TGNT) (“the Company”), a provider of intelligent business marketing and data solutions, today announced that it is evaluating the potential relaunch of its crypto mining operations as part of the Company’s strategic initiatives for 2026. This review follows the Company’s recent completion of QA testing across key components of the Totaligent platform, including Smart Capture, Display Ads, Analytics, Pulse, and campaign management tools, supporting the platform’s continued progression toward broader market deployment. As the platform advances, Totaligent is expanding its focus to include a review of its technology roadmap and operational requirements to support future product enhancements and scalability. Evaluating AI Capabilities and Strategic Participation...

Continue reading

Robex Shareholders Approve PDI Merger

QUEBEC CITY, Dec. 30, 2025 (GLOBE NEWSWIRE) — Robex Resources Inc. (“Robex” or the “Company”) is pleased to announce that at its special meeting of shareholders (the “Meeting”) held today, shareholders (“Robex Shareholders”) voted overwhelmingly in favour of the special resolution (the “Arrangement Resolution”) approving the previously announced merger with Predictive Discovery Limited (“Predictive”) pursuant to which Predictive, through its direct wholly-owned subsidiary, will acquire all of the issued and outstanding common shares of Robex (“Robex Shares”) by way of a statutory plan of arrangement under the Business Corporations Act (Québec). Voting Results The Arrangement Resolution was approved by 94.54% of votes cast by Robex Shareholders represented in person or by proxy at the Meeting, satisfying the required approval threshold...

Continue reading

Visionary Holdings (Nasdaq: GV) Appoints CEO of Health Technology Business, Establishes New Sales Entity in Nanjing to Accelerate Commercial Execution in China Market

HONG KONG, Dec. 30, 2025 (GLOBE NEWSWIRE) — Visionary Holdings Inc. (“GV” or the “Company”), a technology-driven multinational enterprise listed on Nasdaq (Nasdaq: GV), today announced that its wholly owned subsidiary, Visionary Health Technology Group Limited(“GV Hong Kong”), has official appointed Ms. Wenxuan Cai as Chief Executive Officer of GV Hong Kong, effective immediately. In parallel, the GV Hong Kong has established a new wholly owned subsidiary in Nanjing, China, dedicated primarily to sales execution and market development. This milestone marks GV’s formal transition from strategic positioning to active on-the-ground revenue generation. Strengthening Leadership to Drive Market Execution Ms. Cai joins the Company with nearly two decades of extensive experience in market expansion, brand commercialization, and building...

Continue reading

Nukkleus Completes Tiltan Acquisition, Adds 30 Years of Defense AI Leadership to Portfolio

Israeli defense technology pioneer, supplier to IAI, Elbit, and Rafael, now a wholly owned Nukkleus subsidiary NEW YORK and TEL AVIV, Israel, Dec. 30, 2025 (GLOBE NEWSWIRE) — Nukkleus Inc. (NASDAQ: NUKK), (the “Company”), a strategic acquirer and developer of high-growth aerospace and defense businesses, today announced the closing of its acquisition of Tiltan Software Engineering Ltd. (“Tiltan”), a 30-year leader in defense AI simulation, synthetic data generation, and GPS-denied navigation systems. Tiltan is now a wholly owned subsidiary of the Company. Tiltan’s technology is embedded in some of the world’s most advanced defense programs. Tiltan’s simulation platforms train pilots and operators for Israel Aerospace Industries, its synthetic data accelerates machine learning development for Elbit Systems, and its GPS-denied...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.